Archive 1995–2023
2000, volume 16, issue 2
Article
Problem placebo w badaniach klinicznych leków przeciwdepresyjnych
Stanisław Pużyński1
1. II Klinika Psychiatryczna Instytutu Psychiatrii i Neurologii w Warszawie
Farmakoterapia w Psychiatrii i Neurologii, 2000, 2, 122-131
Summary
The author analyses ethical concerns about the double blind, placebo controlled trials in development of new antidepressants. He concludes that the placebo procedure is not a necessary condition for methodological correctness of clinical trials and should not be applied to sick people.